Rollins Financial Johnson & Johnson Transaction History

Rollins Financial

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $103,521 - $112,963	-711 Reduced 17.12%	3,441 $539,000
Q3 2023 Nov 09, 2023	SELL	$155.75 - $174.48 $139,396 - $156,159	-895 Reduced 17.73%	4,152 $646,000
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $371,520 - $399,826	2,407 Added 91.17%	5,047 $835,000
Q1 2023 May 03, 2023	SELL	$151.05 - $180.26 $16,917 - $20,189	-112 Reduced 4.07%	2,640 $409,000
Q4 2022 Feb 06, 2023	BUY	$160.2 - $179.79 $18,423 - $20,675	115 Added 4.36%	2,752 $486,000
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $179,398 - $199,626	-1,112 Reduced 29.66%	2,637 $431,000
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $148,848 - $164,618	-885 Reduced 19.1%	3,749 $666,000
Q1 2022 May 04, 2022	BUY	$158.14 - $179.59 $316 - $359	2 Added 0.04%	4,634 $821,000
Q4 2021 Feb 01, 2022	BUY	$155.93 - $173.01 $12,474 - $13,840	80 Added 1.76%	4,632 $792,000
Q2 2021 Aug 04, 2021	BUY	$159.48 - $171.07 $214,500 - $230,089	1,345 Added 41.94%	4,552 $750,000
Q1 2021 May 21, 2021	BUY	$153.07 - $170.48 $47,910 - $53,360	313 Added 10.82%	3,207 $527,000
Q4 2020 Mar 25, 2021	BUY	$137.11 - $157.38 $396,796 - $455,457	2,894 New	2,894 $455,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Rollins Financial, based on Form 13F filings with the SEC.

Stay updated on Rollins Financial with notifications on news.